| 发明名称 |
MGLU 2/3 AGONISTS |
| 摘要 |
The present invention provides novel mGlu2/3 agonists of the formula wherein R1, R2, and R3 are as defined herein, for use in the treatment of neurological or psychiatric disorders. |
| 申请公布号 |
LT2809647(T) |
申请公布日期 |
2016.10.10 |
| 申请号 |
LT20130702872T |
申请日期 |
2013.01.29 |
| 申请人 |
Eli Lilly and Company |
发明人 |
BAKER, Stephen, Richard;BEADLE, Christopher David;CLARK, Barry Peter;MONN, James Allen;PRIETO, Lourdes |
| 分类号 |
C07C271/24;A61K31/16;A61K31/195;A61K31/215;A61K31/325;A61P25/18;A61P29/00;C07C229/50;C07C233/52;C07C237/12;C07C323/60;C07K5/06 |
主分类号 |
C07C271/24 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
